Pfizer Inc and its German partner BioNTech SE have submitted to U.S. regulators the initial data from an early-stage trial toward seeking authorization of a booster dose of their COVID-19 vaccine, the...
https://ift.tt/eA8V8J
https://ift.tt/eA8V8J
Comments
Post a Comment